Literature DB >> 9692312

Ofuji's papuloerythroderma: a study of 17 cases.

N Bech-Thomsen1, K Thomsen.   

Abstract

In this retrospective study the clinical, laboratory and histological features, treatment methods and disease course in 17 patients with papuloerythroderma (PE) are reviewed. The median age at diagnosis was 72 years and the female/male ratio was 1:4:7. The most common abnormal laboratory findings were eosinophilia and an elevated serum IgE level. Psoralen photochemotherapy (PUVA) and oral prednisolone 10-20 mg daily given in combination or alone were very efficient treatments, while UVB phototherapy in combination with topical steroids was also successful. However, potent topical corticosteroids alone or in combination with oral antihistamines were not effective. The patients were observed for a median of 19 months from diagnosis, three being followed for more than 5 years. Five of the patients relapsed, but only one had multiple relapses, two developed cutaneous T-cell lymphoma (CTCL) and two others had histological features suggestive of that disorder. Six of the patients died, cardiovascular disease being the most common cause. PE is a distinct clinical entity with a polymorphous aetiology which frequently includes an association with CTCL or visceral malignancy. PUVA, oral corticosteroids and UVB in combination with topical corticosteroids appear to be effective therapeutic modalities.

Entities:  

Mesh:

Year:  1998        PMID: 9692312     DOI: 10.1046/j.1365-2230.1998.00238.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Dermatosis as the initial presentation of gastric cancer: two cases.

Authors:  Wei Ge; Bu-Wei Teng; De-Cai Yu; Gang Chen; Li-Ming Zheng; Yi-Tao Ding
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

2.  The Importance of Excluding Cutaneous T-Cell Lymphomas in Patients with a Working Diagnosis of Papuloerythroderma of Ofuji: A Case Series.

Authors:  Anthony M Maher; Chloé E Ward; Steven Glassman; Ivan V Litvinov
Journal:  Case Rep Dermatol       Date:  2018-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.